XML 21 R7.htm IDEA: XBRL DOCUMENT v3.26.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities    
Net income $ 9,794 $ 8,371
Adjustments to reconcile net income to net cash provided by operating activities:    
Provisions for credit losses 3,320 3,842
Depreciation and amortization 1,450 1,315
Stock-based compensation 495 410
Deferred taxes (77) (642)
Other items [1] (2,825) 74
Net decrease in Card balances held for sale 69 0
Changes in operating assets and liabilities, net of effects of acquisitions and dispositions:    
Other assets (1,298) (1,333)
Accounts payable & other liabilities 3,631 3,324
Net cash provided by operating activities 14,559 15,361
Cash Flows from Investing Activities    
Sale of investments [2] 28 42
Maturities and redemptions of investments 808 876
Purchase of investments (5,324) (1,314)
Net increase in Card balances and Other loans, including Card balances held for sale (8,878) (10,212)
Purchase of premises and equipment, net of sales [3] (2,994) (1,703)
Acquisitions, net of cash acquired (524) (633)
Net cash used in investing activities (16,884) (12,944)
Cash Flows from Financing Activities    
Net increase in customer deposits 2,446 10,439
Net (decrease) increase in short-term borrowings (140) 1
Proceeds from long-term debt [3] 10,895 22,375
Payments of long-term debt (7,823) (14,896)
Issuance of American Express preferred shares 1,584 0
Redemption of American Express preferred shares (1,600) 0
Issuance of American Express common shares 14 48
Repurchase of American Express common shares and other (5,805) (4,915)
Dividends paid (1,916) (1,688)
Net cash (used in) provided by financing activities (2,345) 11,364
Effect of foreign currency exchange rates on cash and cash equivalents 81 285
Net (decrease) increase in cash and cash equivalents (4,589) 14,066
Cash and cash equivalents at beginning of period 47,792 40,640
Cash and cash equivalents at end of period $ 43,203 $ 54,706
[1] Primarily includes gains/losses on fair value hedges, foreign currency transactions, Amex Ventures and tax credits investments and movements in equity method investments. In addition, the amount for the nine months ended September 30, 2026 includes the gain recognized on the sale of our equity method investment in Global Business Travel Group, Inc. (GBTG). Refer to Note 1 for additional information.
[2] Excludes $1.5 billion of non-cash activity related to the sale of our equity method investment in GBTG, which was recorded as a receivable in Other assets on the Consolidated Balance Sheets as of September 30, 2026. Proceeds from the sale were subsequently received.
[3] Excludes an increase of $370 million related to non-cash activity for a finance lease. Refer to Note 1 for additional information.